AEON BIOPHARMA, INC.
Last · —$0.229-0.001 (-0.43%)live · yahoo · 0s ago
Market cap$11.42M49.9M sh
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.192$1.40
Volume1.1Msession
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-30
- Operating Cf Burn
- Cash Runway Low
- Current Ratio Low
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.2 years
- Current Ratio Low — Current ratio 0.49
Press & signals
- GlobeNewswire
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
- GlobeNewswire
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- GlobeNewswire
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags